ProCE Banner Activity

MM5: Guidance on Clinical Management of Mild to Moderate COVID-19

Multimedia
In this presentation, Dr. Adaora Adimora discusses medical management for mild to moderate COVID-19, including current treatment recommendations and data on investigational therapies.

Released: June 18, 2020

Expiration: June 17, 2021

Share

Faculty

Ada Adimora

Ada Adimora, MD, MPH

Sarah Graham Kenan Distinguished Professor of Medicine
Attending

Division of Infectious Diseases
Department of Medicine
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Educational grant provided by

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Ada Adimora, MD, MPH

Sarah Graham Kenan Distinguished Professor of Medicine
Attending

Division of Infectious Diseases
Department of Medicine
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Adaora A. Adimora, MD, MPH, has disclosed that she has received funds for research support from Gilead Sciences and consulting fees from Gilead Sciences, Merck, and ViiV Healthcare.